Evidence map›Paper›PMID 26388859›Full record

ArticleFrontiers in microbiology2015

Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate.

Sandra Mota, Rosana Alves, Catarina Carneiro, Sónia Silva, Alistair J Brown, Fabian Istel, Karl Kuchler, Paula Sampaio, Margarida Casal, Mariana Henriques and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 50 citations in OpenAlex.

  1. Activity ofVirulence · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Two promising natural lipopeptides fromActa biochimica Polonica · 2024
    Article
  6. Two promisingFrontiers in pharmacology · 2024
    Article
  7. Strain and temperature dependent aggregation ofCell surface (Amsterdam, Netherlands) · 2023
    Article
  8. Article
  9. Article
  10. Role of Cellular Metabolism duringPathogens (Basel, Switzerland) · 2022
    Review
  11. Review
  12. The Flo Adhesin Family.Pathogens (Basel, Switzerland) · 2021
    Review
  13. Journal of fungi (Basel, Switzerland) · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Sandra MotaCentre of Molecular and Environmental Biology, Department of Biology, University of Minho Braga, Portugal ; Centre of Health and Environmental Research, School of Allied Health Sciences, Polytechnic Institute of Porto Porto, Portugal.
Rosana AlvesCentre of Molecular and Environmental Biology, Department of Biology, University of Minho Braga, Portugal.
Catarina CarneiroCentre of Molecular and Environmental Biology, Department of Biology, University of Minho Braga, Portugal.
Sónia SilvaCentre for Biological Engineering, University of Minho Braga, Portugal.
Alistair J BrownInstitute of Medical Sciences - School of Medical Sciences, University of Aberdeen Aberdeen, UK.
Fabian IstelDepartment of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna Vienna, Austria.
Karl KuchlerDepartment of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna Vienna, Austria.
Paula SampaioCentre of Molecular and Environmental Biology, Department of Biology, University of Minho Braga, Portugal.
Margarida CasalCentre of Molecular and Environmental Biology, Department of Biology, University of Minho Braga, Portugal.
Mariana HenriquesCentre for Biological Engineering, University of Minho Braga, Portugal.
Sandra PaivaCentre of Molecular and Environmental Biology, Department of Biology, University of Minho Braga, Portugal.
University of Minho · PTMedical University of Vienna · ATPolytechnic Institute of Porto · PTUniversity of Aberdeen · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida glabrata is considered a major opportunistic fungal pathogen of humans. The capacity of this yeast species to cause infections is dependent on the ability to grow within the human host environment and to assimilate the carbon sources available. Previous studies have suggested that C. albicans can encounter glucose-poor microenvironments during infection and that the ability to use alternative non-fermentable carbon sources, such as carboxylic acids, contributes to the virulence of this fungus. Transcriptional studies on C. glabrata cells identified a similar response, upon nutrient deprivation. In this work, we aimed at analyzing biofilm formation, antifungal drug resistance, and phagocytosis of C. glabrata cells grown in the presence of acetic acid as an alternative carbon source. C. glabrata planktonic cells grown in media containing acetic acid were more susceptible to fluconazole and were better phagocytosed and killed by macrophages than when compared to media lacking acetic acid. Growth in acetic acid also affected the ability of C. glabrata to form biofilms. The genes ADY2a, ADY2b, FPS1, FPS2, and ATO3, encoding putative carboxylate transporters, were upregulated in C. glabrata planktonic and biofilm cells in the presence of acetic acid. Phagocytosis assays with fps1 and ady2a mutant strains suggested a potential role of FPS1 and ADY2a in the phagocytosis process. These results highlight how acidic pH niches, associated with the presence of acetic acid, can impact in the treatment of C. glabrata infections, in particular in vaginal candidiasis.

Indexed as

acetateantifungal drug resistanceCandida glabratacandidiasisfluconazolephagocytosistransporters

Identifiers

PMID26388859
PMCPMC4560035
OpenAlexW1821298691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.